Credit: psychiatryadvisior.com
Metabolic syndrome and cardiovascular diseases are important causes of morbidity and mortality among patients with severe mental illnesses. Atypical or second-generation antipsychotics (SGAs) are associated with obesity and other components of metabolic syndrome, particularly abnormal glucose and lipid metabolism. With reference to recent academic literature and clinical practice, describe both the wanted and unwanted effects of second generation, atypical anti-psychotic medications (SGA’s).
Continue reading
Recent Comments